US Patent Issued to Singapore Health Services on Dec. 30 for "Cancer therapeutic targeting using mutant P53-specific siRNAs" (Singaporean Inventor)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,277, issued on Dec. 30, was assigned to Singapore Health Services PTE LTD (Singapore).

"Cancer therapeutic targeting using mutant P53-specific siRNAs" was invented by Kanaga Sabapathy (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are nucleic acid sequences for targeting one or more single point mutations within a target gene, wherein the target gene is one or more tumour suppressor genes; wherein the tumour suppressor gene is p53; and methods of treating cancer in a subject comprising administering the same."

The patent was filed on Feb. 21, 2019, under Application No. 16/971,626.

*For further information, including ima...